Safety and effectiveness of biphasic insulin aspart 30 in Chinese patients with type 2 diabetes: results from the A1chieve study

医学 门冬氨酸胰岛素 内科学 人口 糖尿病 观察研究 2型糖尿病 2型糖尿病 胰岛素 养生 低血糖 内分泌学 环境卫生
作者
Wenying Yang,Yuxiu Li,Liming Chen,Yongquan Shi,Yongde Peng
出处
期刊:Chin J Diabetes Mellitus 卷期号:4 (10): 607-612 被引量:1
标识
DOI:10.3760/cma.j.issn.1674-5809.2012.10.007
摘要

Objective To evaluate clinical safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in Chinese patients with type 2 diabetes mellitus(T2DM) inadequately controlled on their previous treatments. Methods A1chieve study was a prospective, open-label, 24-week observational study in patients with type 2 diabetes initiating insulin analogues therapy in routine clinical practice. From November 2008 to March 2011, eligible patients who had decided to start BIAsp 30 based on physicians' clinical judgments were enrolled into this study from 130 hospitals in China. The overall study population contains 8578 Chinese patients with T2DM who were treated with BIAsp 30. Among the overall study population, a subgroup of 1191 patients was treated with biphasic human insulin before study. The treatment regimen and dosing adjustment were decided at physician's discretion. Results The rates of total, major, and nocturnal hypoglyceamia (events/patient/year) of the overall study population were 2.32, 0.15, 0.58 at baseline and 1.54, 0.00, 0.28 at week 24 for the overall population (Fisher exact test P<0.05, P<0.01, P<0.01). Glycaemic control was poor at baseline reflected by HbA1c (9.5±2.3) %. After 24 weeks treatment, HbA1c of the overall study population decreased to (7.0±1.0) % (P<0.01). Fasting plasma glucose (FPG) and post-prandial plasma glucose (PPG) were both improved for the overall population (changes were (-3.5±3.6) mmol/L and (-5.5±5.0) mmol/L, with both P value <0.01). The rates of total, major, and nocturnal hypoglyceamia (events/patient/year) were 7.20, 0.51, 2.15 at baseline and 2.37, 0.00, 0.43 at week 24 for subgroup patients (all P value <0.01). The HbA1c of these patients decreased from (8.7±2.1) % at baseline to (7.0±1.1) % at week 24 (P<0.01). Conclusion Beginning BIAsp 30 therapy in Chinese patients with T2DM inadequately controlled on previous treatment is associated with marked improvements in glycaemic control, without evidence of clinically significant safety or tolerability concerns, regardless of the previous treatment regimen. Key words: Biphasic insulin aspart 30; Diabetes mellitus, type 2; Hypoglycaemia; Insulin analogues
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
传奇3应助糖堆儿爱吃糖采纳,获得10
刚刚
Coco发布了新的文献求助10
刚刚
KYpaopao发布了新的文献求助10
1秒前
1秒前
如梦发布了新的文献求助10
1秒前
iwww发布了新的文献求助10
2秒前
从容灵松发布了新的文献求助10
2秒前
夏天呀完成签到,获得积分10
3秒前
乖猫要努力应助浅浅采纳,获得10
3秒前
zzzzzzz发布了新的文献求助10
3秒前
生动的翠容完成签到,获得积分10
4秒前
yy关闭了yy文献求助
4秒前
musejie发布了新的文献求助10
5秒前
坚果发布了新的文献求助10
5秒前
6秒前
Andy1201应助Hatexist采纳,获得50
6秒前
Jasmine发布了新的文献求助10
6秒前
7秒前
彳亍发布了新的文献求助10
7秒前
彭于晏应助gwff采纳,获得10
7秒前
7秒前
曼凡发布了新的文献求助10
8秒前
9秒前
9秒前
zzzzzzz完成签到,获得积分10
9秒前
大模型应助wangchaofk采纳,获得10
10秒前
禾风发布了新的文献求助10
10秒前
wang123发布了新的文献求助20
10秒前
好奇宝宝发布了新的文献求助10
11秒前
11秒前
元谷雪发布了新的文献求助10
11秒前
陌疑应助白鸽鸽采纳,获得10
12秒前
陶醉元冬完成签到,获得积分10
13秒前
13秒前
NJP发布了新的文献求助10
13秒前
111发布了新的文献求助10
14秒前
淡淡雨琴发布了新的文献求助10
14秒前
14秒前
史彦钊完成签到,获得积分10
15秒前
吴大打发布了新的文献求助10
15秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3971277
求助须知:如何正确求助?哪些是违规求助? 3515939
关于积分的说明 11180280
捐赠科研通 3251061
什么是DOI,文献DOI怎么找? 1795664
邀请新用户注册赠送积分活动 875937
科研通“疑难数据库(出版商)”最低求助积分说明 805209